世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033018

ウイルスベクターの世界市場(2022-2026)

TechNavio

Global Viral Vectors Market 2022-2026

発刊日 2022/08/26

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000033018

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、ウイルスベクター市場を分析します。

世界のウイルスベクター市場は、予測期間中に約14.23 %のCAGRで推移し、2022年から2026年の間に4億9,064万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。この市場は、慢性疾患の増加、遺伝子治療やワクチン開発におけるウイルスベクターの利用拡大、遺伝子治療やワクチンに対する資金調達や投資の増加によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 用途別
      ◇ 遺伝子治療
      ◇ ワクチン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、今後数年間におけるウイルスベクター市場の成長を促進する主な理由の一つとして、ウイルスベクターを用いた遺伝子治療やワクチン開発のための研究開発活動が増加していることを挙げています。また、M&Aや提携の増加、ウイルスベクター製造のための新技術の出現は、市場の大きな需要につながると考えられます。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • ウイルスベクターの市場規模
  • ウイルスベクターの市場予測
  • ウイルスベクター市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なウイルスベクター市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Batavia Biosciences BV
    ➣ Bayer AG
    ➣ Catalent Inc.
    ➣ Creative Biogene
    ➣ Danaher Corp.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ FinVector Oy
    ➣ Freeline Therapeutics Holdings plc
    ➣ 富士フイルムホールディングズ(FUJIFILM Holdings Corp.)
    ➣ Institut Merieux
    ➣ Lonza Group Ltd.
    ➣ Merck KGaA
    ➣ Novartis AG
    ➣ Oxford Biomedica Plc
    ➣ REGENXBIO Inc.
    ➣ Sirion Biotech GmbH
    ➣ 宝ホールディングス(Takara Holdings Inc.)
    ➣ Thermo Fisher Scientific Inc.
    ➣ uniQure NV
    ➣ Virovek Inc.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application
5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Gene therapy - Market size and forecast 2021-2026
Exhibit 28: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
5.4 Vaccines - Market size and forecast 2021-2026
Exhibit 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Application
Exhibit 36: Market opportunity by Application ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 UK - Market size and forecast 2021-2026
Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Batavia Biosciences BV
Exhibit 85: Batavia Biosciences BV - Overview
Exhibit 86: Batavia Biosciences BV - Product / Service
Exhibit 87: Batavia Biosciences BV - Key offerings
10.4 Bayer AG
Exhibit 88: Bayer AG - Overview
Exhibit 89: Bayer AG - Business segments
Exhibit 90: Bayer AG - Key offerings
Exhibit 91: Bayer AG - Segment focus
10.5 Creative Biogene
Exhibit 92: Creative Biogene - Overview
Exhibit 93: Creative Biogene - Product / Service
Exhibit 94: Creative Biogene - Key offerings
10.6 F. Hoffmann La Roche Ltd.
Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
10.7 FinVector Oy
Exhibit 100: FinVector Oy - Overview
Exhibit 101: FinVector Oy - Product / Service
Exhibit 102: FinVector Oy - Key offerings
10.8 FUJIFILM Holdings Corp
Exhibit 103: FUJIFILM Holdings Corp - Overview
Exhibit 104: FUJIFILM Holdings Corp - Business segments
Exhibit 105: FUJIFILM Holdings Corp - Key offerings
Exhibit 106: FUJIFILM Holdings Corp - Segment focus
10.9 Lonza Group Ltd.
Exhibit 107: Lonza Group Ltd. - Overview
Exhibit 108: Lonza Group Ltd. - Business segments
Exhibit 109: Lonza Group Ltd. - Key news
Exhibit 110: Lonza Group Ltd. - Key offerings
Exhibit 111: Lonza Group Ltd. - Segment focus
10.10 Merck KGaA
Exhibit 112: Merck KGaA - Overview
Exhibit 113: Merck KGaA - Business segments
Exhibit 114: Merck KGaA - Key news
Exhibit 115: Merck KGaA - Key offerings
Exhibit 116: Merck KGaA - Segment focus
10.11 Oxford Biomedica Plc
Exhibit 117: Oxford Biomedica Plc - Overview
Exhibit 118: Oxford Biomedica Plc - Business segments
Exhibit 119: Oxford Biomedica Plc - Key offerings
Exhibit 120: Oxford Biomedica Plc - Segment focus
10.12 Thermo Fisher Scientific Inc.
Exhibit 121: Thermo Fisher Scientific Inc. - Overview
Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
Exhibit 123: Thermo Fisher Scientific Inc. - Key news
Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Batavia Biosciences BV - Overview
Exhibits86: Batavia Biosciences BV - Product / Service
Exhibits87: Batavia Biosciences BV - Key offerings
Exhibits88: Bayer AG - Overview
Exhibits89: Bayer AG - Business segments
Exhibits90: Bayer AG - Key offerings
Exhibits91: Bayer AG - Segment focus
Exhibits92: Creative Biogene - Overview
Exhibits93: Creative Biogene - Product / Service
Exhibits94: Creative Biogene - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Overview
Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
Exhibits97: F. Hoffmann La Roche Ltd. - Key news
Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits100: FinVector Oy - Overview
Exhibits101: FinVector Oy - Product / Service
Exhibits102: FinVector Oy - Key offerings
Exhibits103: FUJIFILM Holdings Corp - Overview
Exhibits104: FUJIFILM Holdings Corp - Business segments
Exhibits105: FUJIFILM Holdings Corp - Key offerings
Exhibits106: FUJIFILM Holdings Corp - Segment focus
Exhibits107: Lonza Group Ltd. - Overview
Exhibits108: Lonza Group Ltd. - Business segments
Exhibits109: Lonza Group Ltd. - Key news
Exhibits110: Lonza Group Ltd. - Key offerings
Exhibits111: Lonza Group Ltd. - Segment focus
Exhibits112: Merck KGaA - Overview
Exhibits113: Merck KGaA - Business segments
Exhibits114: Merck KGaA - Key news
Exhibits115: Merck KGaA - Key offerings
Exhibits116: Merck KGaA - Segment focus
Exhibits117: Oxford Biomedica Plc - Overview
Exhibits118: Oxford Biomedica Plc - Business segments
Exhibits119: Oxford Biomedica Plc - Key offerings
Exhibits120: Oxford Biomedica Plc - Segment focus
Exhibits121: Thermo Fisher Scientific Inc. - Overview
Exhibits122: Thermo Fisher Scientific Inc. - Business segments
Exhibits123: Thermo Fisher Scientific Inc. - Key news
Exhibits124: Thermo Fisher Scientific Inc. - Key offerings
Exhibits125: Thermo Fisher Scientific Inc. - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations

この商品のレポートナンバー

0000033018

TOP